Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus

European Respiratory Journal

Volumn 31, Issue 1, 2008, Pages 213-217

  Guglielmi, S ^a   Merz, T M ^a   Gugger, M ^a   Suter, C ^a   Nicod, L P ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antisynthetase syndrome; Dermatomyositis; Interstitial lung diseases; Interstitial pulmonary fibrosis; Nonspecific interstitial pneumonia; Polymyositis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DOXYCYCLINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; METHYLPREDNISOLONE; PREDNISONE; RIFAMPICIN; STEROID; TACROLIMUS; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ANTISYNTHETASE SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOW DRUG DOSE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; CD8+ T LYMPHOCYTE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; INTERSTITIAL LUNG DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; POLYMYOSITIS; SYNDROME;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYOSITIS; RESPIRATORY DISTRESS SYNDROME, ADULT; SYNDROME; TACROLIMUS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 45849139382     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00014707     Document Type: Article

References (20)

1. Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12: 501-508.
2. Takiawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 1987; 14: 102-107.
3. Marie I, Hachulla E, Chérin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47: 614-622.
4. Sauty A, Rochat T, Schoch OD, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997; 10: 2907-2912.
5. Nawata Y, Kurasawa K, Takabayashi K, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999; 26: 1527-1533.
6. Miyake S, Ohtani Y, Sawada M, et al. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 128-133.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis: first of two parts. N Engl J Med 1975; 292: 344-347.
8. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988; 18: 29-37.
9. Ascherman DP. The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses. Curr Rheumatol Rep 2003; 5: 425-430.
10. Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis and Coxsackie-virus infection. Lancet 1987; 1: 1004-1007.
11. Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Chérin P. Antisynthetase-syndrome. Joint Bone Spine 2003; 70: 161-168.
12. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-374.
13. Cottin V, Thivolet-Béjui F, Reynaud-Gaubert M, et al. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires. Interstital Lung Disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003; 22: 245-250.
14. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis- dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182-1185.
15. Takada K, Nagasaka K, Mijasaka N. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunitiy 2005; 38: 383-392.
16. Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2005; 17: 701-706.
17. Bonnefoy O, Ferretti G, Calaque O, et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol 2004; 49: 235-244.
18. Fujisawa T, Suda T, Nakamura Y, et al. Difference in clinical features and prognosis of interstitial lung disease between polymyositis and dermatomyositis. J Rheumatol 2005; 32: 58-64.
19. Oddis CV, Sciurba FC, Elmagd KA, Starzl TE. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999; 353: 1762-1763.
20. Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 2005; 52: 2439-2446.